Saidal sale lacks interest
Pharmaceuticals company Saidal is struggling to attract interest in its privatisation, with at least two of the financial firms shortlisted to advise on the sale expected not to bid.Seven shortlisted companies have been invited to submit bids in early May for the financial advisory contract on the sale of the state-owned business. However, sources close to the project say at least two of the companies will not go ahead.The companies invited to bid are: BNP Paribas, Citigroup, ...
Subscriber access only
Sign In
- If you are a new, paid MEED subscriber accessing the site for the first time, please activate your account.
- If you are a registered user who would like to to enjoy unlimited access to MEED.com, click subscribe to purchase a subscription or contact Customer Service by email or by calling +971 (0) 4 368 1588.
- Alternatively, you may browse MEED.com as a registered user for free. Our quick registration will allow you to sample premium business intelligence which is otherwise only available to paying subscribers through our Editor's Choice section, sign up for newsletters and to set up a library of saved articles.
